Companies: 10,795·Total market cap: $144.5T
ALX Oncology Holdings Inc.

ALX Oncology Holdings Inc.

ALXONASDAQHealthcare● Active
$1.59
+$0.02(+1.27%)
Market Cap$213955038
P/E Ratio
52W High$2.66
52W Low$0.404

ALX Oncology Holdings Inc.(ALXO)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · ALXO · 截至 2026-06-09

财务报表

Revenue · Gross Profit · Net Income
Breakdown2025-122024-122023-122022-122021-12
Revenue
Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Cost of Revenue$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Profit$0.00B$0.00B$0.00B$0.00B$0.00B
Gross Margin %(computed)
Operating Expenses
R&D Expenses$0.08B$0.12B$0.14B$0.10B$0.06B
G&A Expenses$0.02B$0.03B$0.03B$0.03B$0.02B
Total Operating Expenses$0.10B$0.14B$0.17B$0.13B$0.08B
Operating Income($0.10B)($0.14B)($0.17B)($0.13B)($0.08B)
Operating Margin %(computed)
Interest Income$0.00B$0.01B$0.01B$0.00B$0.00B
Interest Expense$0.00B$0.00B$0.00B$0.00B$0.00B
Income Before Tax($0.10B)($0.13B)($0.16B)($0.12B)($0.08B)
Income Tax Expense$0.00B$0.00B$0.00B$0.00B($0.00B)
Net Income($0.10B)($0.13B)($0.16B)($0.12B)($0.08B)
Net Margin %(computed)
Per Share & EBITDA
EPS (Basic)$-1.90$-2.58$-3.74$-3.03$-2.07
Wtd Avg Shares0.05B0.05B0.04B0.04B0.04B
EBITDA($0.10B)($0.13B)($0.16B)($0.12B)($0.08B)
EBITDA Margin %(computed)

数据来源:Financial Modeling Prep · 最后更新:2026-06-09 · USD · B

深入了解ALX Oncology Holdings Inc.

关于ALX Oncology Holdings Inc.(ALXO)损益表

ALX Oncology Holdings Inc.(ALXO)损益表数据来源于SEC Form 10-K及10-Q申报文件。2025财年,ALXO实现营收$0.00B,毛利润$0.00B(毛利率—),净利润($0.10B)(净利率—)。

常见问题

ALXO · 4 问

ALX Oncology Holdings Inc.(ALXO)2025财年营收为$0.00B,同比down—%。

ALXO revenueALXO salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-09